Psyence Biomedical Ltd. Share Price
NASDAQ: PBMPsyence Biomedical Ltd. Stock Performance
Psyence Biomedical Ltd. Share Price Today
As of 29 October 2026, Psyence Biomedical Ltd.'s share price is $3.79. The stock opened at $3.57, compared to its previous close of $3.16. During today's trading session, Psyence Biomedical Ltd.'s share price traded between $3.57 and $3.80, with an average price of $3.68. Over the past 52 weeks, the stock has recorded a high of $16.88 and a low of $0.62. In terms of performance, Psyence Biomedical Ltd.'s share price has declined by 42.50% over the last six months and is up 17.13% on a year-on-year basis.
Psyence Biomedical Ltd. Share Price Chart
Psyence Biomedical Ltd. Annual Profit & Loss
All figures in USD
About Psyence Biomedical Ltd.
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
Psyence Biomedical Ltd. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $5.47 | $3.80 | -31.16% |
Sep 2026 | $4.33 | $5.52 | +26.32% |
Aug 2026 | $3.21 | $4.37 | +36.14% |
Jul 2026 | $3.21 | $3.21 | +6.64% |
Jun 2026 | $4.27 | $3.01 | -28.50% |
May 2026 | $6.53 | $4.21 | -36.21% |
Apr 2026 | $2.50 | $6.60 | +167.21% |
Mar 2026 | $2.61 | $2.47 | -1.59% |
Feb 2026 | $4.23 | $2.51 | +292.19% |
Jan 2026 | $0.76 | $0.64 | -13.75% |
Dec 2025 | $1.58 | $0.74 | -52.13% |
Nov 2025 | $3.05 | $1.55 | -52.16% |